A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years

A RIVA-DM Subanalysis Investigating Patients With Nonvalvular Atrial Fibrillation and Type 2 Diabetes Aged Under Versus Over 80 Years

Background Advanced age and type 2 diabetes (T2D) are common in patients with nonvalvular atrial fibrillation (NVAF). We evaluated the impact of age on the effectiveness and safety of rivaroxaban versus warfarin in this population. Methods We analyzed electronic health record data from November 2010...

Full description

Bibliographic Details
Main Authors: Craig I. Coleman Pharma D, FASHP, FACC, Olivia S. Costa PharmD, Christopher W. Brescia BS, Burcu Vardar MD, Khaled Abdelgawwad MSc, Lucas Hofmeister PhD, Nitesh Sood MD
Format: Article
Language:English
Published: SAGE Publishing 2022-11-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296221133083

Internet

https://doi.org/10.1177/10760296221133083

Similar Items